Elamod is a new type of anti-rheumatic drug that is a modified anti-rheumatic drug. It is mainly used to treat rheumatoid arthritis and produces anti-rheumatic effects mainly by reducing the levels of cytokines such as interleukin I, interleukin VI and tumor necrosis factor. In the course of the study, it was found that Eramod could reduce the symptoms and reduce the swelling and pain of the joints faster in the treatment of rheumatoid arthritis. And it can quickly bring down rheumatoid factor, blood sedimentation, C-reactive protein and other indicators for evaluating rheumatoid arthritis activity more quickly. Also, the side effects of Elamod were found to be less than those of traditional non-steroidal anti-rheumatic drugs, and it has less gastrointestinal reactions and less onset of liver damage than traditional drugs. It is also less expensive compared to biologics.